US FDA Flags Concerns at Piramal Pharma’s Mumbai Plant with Six Observations
Piramal Pharma’s shares are expected to be in focus on Wednesday following the company’s announcement regarding a recent inspection by the U.S. Food and Drug Administration (FDA) at its manufacturing facility in Turbhe, Navi Mumbai. According to the company, the FDA conducted a Good Manufacturing Practice (GMP) inspection at the facility from February 11 to … Read more